IGC Pharma Form S-3 Reporting - IGC Pharma, INC.

SEC

Filings

April 18, 2024

IGC Pharma Form S-3 Reporting

IGC Pharma, Inc. IGC on NYSE

Related Posts

FORM 10-Q

February 18, 2025

FORM TYPE 10-Q

November 12, 2024

8K + XBRL Form 4

September 27, 2024

CEO Update

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

May 12, 2025

IGC Pharma Welcomes Strategic Investment from Advisors

April 24, 2025